Evolution of the Average Target: Moderna, Inc.

average-target-price-chart MODERNA-INC

Evolution of the Target Price: Moderna, Inc.

target-price-consensus-chart MODERNA-INC

Changes in Analyst Recommendations: Moderna, Inc.

735dcd6940848e04.jz1Qe_7WnEMGrWOBdoQKcYk2zmbOYz1fax7Jk2nyN74.xWQ6PLq6qC9M_zzAHbRVOftxpV-nDUUJByuT5jOaYevfDBc9uZjVAXHhWw~633740effe27d01907b80a7d19088ef4
Berenberg Bank Adjusts Moderna Price Target to $33 From $42, Maintains Hold Rating Jan. 16 MT
Analyst recommendations: Datadog, Estee Lauder, Netflix, Moderna, EasyJet... Jan. 16Our Logo
Morgan Stanley Cuts Price Target on Moderna to $38 From $70, Keeps Equalweight Rating Jan. 15 MT
Analyst recommendations: Adobe, Intuit, XPO, Netflix, Tesla... Jan. 15Our Logo
Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating Jan. 14 MT
MODERNA : Oddo BHF lowers its target price Jan. 14 CF
RBC Capital Adjusts Price Target on Moderna to $40 From $50 Jan. 13 MT
UBS Cuts Price Target on Moderna to $96 From $108, Maintains Buy Rating Jan. 08 MT
Argus Downgrades Moderna to Hold From Buy Dec. 18 MT
JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating Nov. 26 MT
Analyst recommendations: Chevron, Morgan Stanley, Goldman Sachs, Affirm Holdings, Moderna... Nov. 26Our Logo
RBC Cuts Price Target on Moderna to $50 From $62, Maintains Sector Perform Rating Nov. 25 MT
Baptista Upgrades Moderna to Buy, Price Target at $48 Nov. 20 MT
Berenberg Initiates Moderna at Hold, With $42 Price Target Nov. 19 MT
MODERNA : Berenberg sticks Neutral Nov. 19 ZD
Piper Sandler Cuts Moderna Price Target to $69 From $115, Maintains Overweight Rating Nov. 18 MT
Leerink Partners Adjusts Moderna Price Target to $31 From $38, Maintains Underperform Rating Nov. 18 MT
Analyst recommendations: Biogen, HP, Moderna, Shell... Nov. 18Our Logo
HSBC Upgrades Moderna to Buy From Hold, Adjusts Price Target to $58 From $82 Nov. 18 MT
Deutsche Bank Adjusts Price Target on Moderna to $60 From $75, Keeps Hold Rating Nov. 12 MT
Moderna: share price down, a broker's analysis Nov. 11 CF
Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks... Nov. 11Our Logo
MODERNA : Oddo BHF lowers its price target Nov. 11 CF
Jefferies Adjusts Moderna Price Target to $50 From $55 Nov. 08 MT
Goldman Sachs Adjusts Moderna Price Target to $112 From $130 Nov. 08 MT
More recommendations

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+99.66%
+15.11%
+26.18%
+31.90%
+34.03%
+10.89%
+12.44%
+3.13%
+11.18%
+25.59%
Average +27.01%
Weighted average by Cap. +25.90%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
34.06USD
Average target price
68.01USD
Spread / Average Target
+99.66%
High Price Target
212.00USD
Spread / Highest target
+522.43%
Low Price Target
27.00USD
Spread / Lowest Target
-20.73%

Analyst Consensus Detail

consensus-detail-chart MODERNA-INC

Consensus revision (last 18 months)

consensus-revision-chart MODERNA-INC

Analysts covering the company

Berenberg Bank
Morgan Stanley
Leerink Partners
RBC Capital Markets
UBS
Argus
JPMorgan Chase
Baptista Research
Piper Sandler
HSBC
BERENBERG Harry Gillis
Deutsche Bank Securities
Jefferies & Co.
Goldman Sachs
Barclays
BofA Securities
TD Cowen
Brookline Capital Markets
Redburn Atlantic
Evercore ISI
Oppenheimer
Oddo BHF
JPMORGAN Jessica Fye
RBC Luca Issi
Redburn
Canaccord Genuity
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
SVB Leerink
Wolfe Research
Chardan
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG MSCI
AA
surperformance-ratings-light-chart MODERNA-INCMore Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRNA Stock
  4. Consensus Moderna, Inc.